Offer - Urjas Oil for just ₹ 1 X
Netromycin 25 Injection 1 Ml is a prescription drug, available for use as Injection. It is typically used for the treatment of Bacterial Infections. Secondary and off-label uses of Netromycin 25 Injection 1 Ml have also been mentioned below.
The optimal dosage of Netromycin 25 Injection 1 Ml is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
Some other side effects of Netromycin 25 Injection 1 Ml have been listed ahead. Such side effects of Netromycin 25 Injection 1 Ml normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
In addition, Netromycin 25 Injection 1 Ml's effect is Severe during pregnancy and Unknown for lactating mothers. Warnings related to Netromycin 25 Injection 1 Ml's effects on the liver, heart and kidney, if any, have been listed below.
Individuals suffering from medical conditions like Parkinson's Disease, Kidney Disease, Kidney Cancer must refrain from the use of Netromycin 25 Injection 1 Ml since this can cause severe adverse effects. Other conditions have been mentioned below in the Netromycin 25 Injection 1 Ml contraindications section.
Besides this, Netromycin 25 Injection 1 Ml may also have severe interaction with some medicines. A complete list of these interactions is given below.
You should also be aware that Netromycin 25 Injection 1 Ml is not safe while driving, and is not addiction.
Netromycin 25 Injection 1 Ml is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Infant (1 month to 2 years) |
|
Neonates (0 to 1 month) |
|
Is the use of Netromycin 25 Injection 1 Ml safe for pregnant women?
Netromycin can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Netromycin 25 Injection 1 Ml safe during breastfeeding?
No research work has been carried out till date on effect of Netromycin on breastfeeding women. So it is not known whether taking Netromycin will cause side effects or not.
What is the effect of Netromycin 25 Injection 1 Ml on the Kidneys?
Netromycin rarely harms the kidneys.
What is the effect of Netromycin 25 Injection 1 Ml on the Liver?
Netromycin does not damage the liver.
What is the effect of Netromycin 25 Injection 1 Ml on the Heart?
Netromycin is not harmful for the heart.
If you are suffering from any of the following diseases, you should not take Netromycin 25 Injection 1 Ml unless your doctor advises you to do so -
Is this Netromycin 25 Injection 1 Ml habit forming or addictive?
No, you will not get addicted to Netromycin 25 Injection 1 Ml.
Is it safe to drive or operate heavy machinery when consuming?
After taking Netromycin 25 Injection 1 Ml you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, but take Netromycin 25 Injection 1 Ml only as per medical advice.
Is it able to treat mental disorders?
Netromycin 25 Injection 1 Ml is unable to treat or cure mental disorders.
Interaction between Food and Netromycin 25 Injection 1 Ml
It is safe to take Netromycin 25 Injection 1 Ml with food.
Interaction between Alcohol and Netromycin 25 Injection 1 Ml
Due to lack of research, there is no information about the side effects of taking Netromycin 25 Injection 1 Ml with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 749-750